Company: SMNR
Filing Date: 2025-08-13
Form Type: 424B3
Source: 0001193125-25-179226
Chunk: 64

Company: Semnur Pharmaceuticals, Inc.
Filing Date: 2025-08-13
Form: 424B3
Chunk 64
---
| • |     | Proposal 4 — The Bylaws Approval                                                                            
 Proposal — to approve and adopt the Proposed Bylaws attached to this proxy statement/prospectus as Annex C. |

| • |     | Proposals                                                                                                                        
 5A-5G — The Advisory Governance Proposals — to approve and adopt, on a non-binding advisory                                      
 basis, a proposal to approve governance provisions contained in the Proposed Charter, as compared to our Current Denali Charter. |

| • |     | Proposal 6 — The Director Election                                                                                                                                                                                                 
 Proposal — to elect, effective as of the consummation of the Business Combination, Jaisim Shah, Henry Ji, Ph.D., Jay Chun, M.D., Ph.D., Dorman Followwill and Yue Alexander Wu, Ph.D. to serve on the New Semnur Board until their 
 respective successors are duly elected and qualified.                                                                                                                                                                              |

| • |     | Proposal 7 —  The Nasdaq Proposal — to                                                                                                                                                                                                              
 approve and adopt the issuance of more than 20% of the issued and outstanding Denali Ordinary Shares in connection with the terms of the Merger Agreement, which will result in a change of control, as required by Nasdaq Listing Rule 5635(a) and 
 (b).                                                                                                                                                                                                                                                |

| • |     | Proposal 8 — The Option Exchange                                                                            
 Proposal — to approve the exchange of Semnur stock options for options relating to New Semnur Common Stock. |

| • |     | Proposal 9 — The Adjournment Proposal — to 
 approve the adjournment of the Meeting.    |

| Q: | What is the quorum requirement for the Meeting? |

| A: | Shareholders representing a majority of the issued and outstanding Denali Ordinary Shares as of the Record Date                                                                                                                                           
 and entitled to vote at the Meeting must be present in person or represented by proxy in order to hold the Meeting and conduct business. This is called a quorum. Denali Ordinary Shares will be counted for purposes of determining if there is a quorum 
 if the shareholder (i) is present in person and entitled to vote at the meeting, or (ii) has properly submitted a proxy card or voting instructions through a broker, bank or nominee. In the absence of